WaveMan
WaveMan · Company
KMTS · Kestra Medical Technologies, Ltd.
> Search tickers & screens ⌘K
LIVE
← All companies

KMTS Kestra Medical Technologies (KMTS) Insider Trading, Ownership & Congress Trades

Medical Devices · Surgical & medical instruments & apparatus · CIK 0001877184
Quote by TradingView
Form 144 · 29
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
72
13F, latest reported quarter
Conversions, 180 days
1
Codes C/M, not in net · $1.7M priced

What the filings say about KMTS

Insiders, 180 days
-$10.1M net sold
11 sellers · 10% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$9.2M
29 notices

Kestra Medical Technologies insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

Over the last 180 days, KESTRA MEDICAL TECHNOLOGIES, LTD. insiders sold a net $10.1M of stock across 53 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.

Insider
Filed
Shares
Value
Since filing
Umberger Traci S
See Remarks
SELL
2026-10-22 SECtraded 2026-10-21
96,404
$2.6M
n/a
Context
  • 6 earlier Form 4 trades (code P or S) here by this insider (1 buy, 5 sales), the last on Aug 4, 2026.
  • The trade is 48.3% of the 199,421 shares held after it.
  • 3 other insiders sold within 30 days.
  • 72 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: See Remarks Umberger Traci S sold about $2.6M of KMTS under a 10b5-1 plan on Oct 21, 2026, the largest insider sale at the company on our record; 3 other insiders sold within 30 days and 72 funds added in the latest 13F quarter.
Umberger Traci S
See Remarks
SELL
2026-10-22 SECtraded 2026-10-21
3,596
$101.0K
n/a
Context
  • 6 earlier Form 4 trades (code P or S) here by this insider (1 buy, 5 sales), the last on Aug 4, 2026.
  • The trade is 1.8% of the 195,825 shares held after it.
  • 3 other insiders sold within 30 days.
  • 72 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: See Remarks Umberger Traci S sold about $101.0K of KMTS under a 10b5-1 plan on Oct 21, 2026; 3 other insiders sold within 30 days and 72 funds added in the latest 13F quarter.
Webster Brian Daniel
See Remarks
SELL
2026-10-22 SECtraded 2026-10-20
13,316
$393.1K
n/a
Context
  • 20 earlier Form 4 trades (code P or S) here by this insider (20 sales), the last on Aug 17, 2026.
  • The trade is 3.0% of the 446,899 shares held after it.
  • 3 other insiders sold within 30 days.
  • 72 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: See Remarks Webster Brian Daniel sold about $393.1K of KMTS under a 10b5-1 plan on Oct 20, 2026; 3 other insiders sold within 30 days and 72 funds added in the latest 13F quarter.
Webster Brian Daniel
See Remarks
SELL
2026-10-22 SECtraded 2026-10-20
1,684
$50.3K
n/a
Context
  • 20 earlier Form 4 trades (code P or S) here by this insider (20 sales), the last on Aug 17, 2026.
  • The trade is 0.4% of the 445,215 shares held after it.
  • 3 other insiders sold within 30 days.
  • 72 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: See Remarks Webster Brian Daniel sold about $50.3K of KMTS under a 10b5-1 plan on Oct 20, 2026; 3 other insiders sold within 30 days and 72 funds added in the latest 13F quarter.
COHEN RAYMOND W
Director
SELL
2026-10-01 SECtraded 2026-09-30
3,330
$97.5K
+4.8%
Context
  • 2 earlier Form 4 trades (code P or S) here by this insider (2 buys), the last on Mar 26, 2026.
  • +3.6% median (+3.6% mean) 90-day return after 2 previous buys.
  • The trade is 6.1% of the 54,790 shares held after it.
  • 7 other insiders sold within 30 days.
  • 72 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director COHEN RAYMOND W sold about $97.5K of KMTS on Sep 30, 2026; 7 other insiders sold within 30 days and 72 funds added in the latest 13F quarter.
53 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to see 48 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
net -$10.1M over 180 days
-$9.2M over 90 days · -$97.9K of it by a 10%+ holder
below 86% of Medical Devices
Congress
no House purchase disclosed in the last 12 months
Funds
72 funds bought in last quarter
more than 55% of Medical Devices
Revenue
+59.0% year over year
more than 88% of Medical Devices
Margin
-138.4% net margin
below 82% of Medical Devices
Buybacks
no share repurchases reported
Short interest
9.7% of the float short (float per yahoo 2026-10-26) · 7.3 days to cover · settled 2026-09-30
more than 65% of Medical Devices
What changed in the last 30 days
Oct 22See Remarks Umberger Traci S sold $2.7M under a 10b5-1 plan (Oct 21)
Why it matters
A 10b5-1 plan schedules trades months ahead, so this says little about what the insider thinks today.
Oct 22See Remarks Webster Brian Daniel sold $443.4K under a 10b5-1 plan (Oct 20)
Why it matters
A 10b5-1 plan schedules trades months ahead, so this says little about what the insider thinks today.
Oct 21Officer Umberger Traci S filed to sell $2.7M by Oct 21 (Form 144)
Why it matters
A Form 144 is a notice of intent to sell; the sale may not happen, and it says nothing about the price.
Oct 20Officer Webster Brian Daniel filed to sell $443.4K by Oct 20 (Form 144)
Why it matters
A Form 144 is a notice of intent to sell; the sale may not happen, and it says nothing about the price.
Oct 1Director COHEN RAYMOND W sold $97.5K (Sep 30)

Watch KMTS

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+10.3%12M
-31%-17%-2%+13%2025-102025-122026-022026-042026-062026-082026-10 2026-10-21 · Umberger Traci S sold $2.6M2026-08-04 · Webster Brian Daniel sold $1.2M2026-08-07 · Mahboob Vaseem sold $667.2K2026-08-17 · Webster Brian Daniel sold $412.2K2025-12-29 · Webster Brian Daniel sold $398.9K2026-10-20 · Webster Brian Daniel sold $393.1K2026-01-15 · Webster Brian Daniel sold $342.0K2026-06-15 · Webster Brian Daniel sold $312.1K2026-08-03 · Webster Brian Daniel sold $311.4K2026-08-03 · Ford Alfred J Jr sold $311.1K2026-03-17 · Webster Brian Daniel sold $304.1K2026-04-15 · Webster Brian Daniel sold $300.6K2026-02-17 · Webster Brian Daniel sold $295.4K2025-12-29 · Umberger Traci S sold $280.2K2026-07-15 · Webster Brian Daniel sold $246.9K2026-07-31 · Webster Brian Daniel sold $202.3K2026-03-26 · COHEN RAYMOND W bought $199.8K2026-07-31 · Mahboob Vaseem sold $199.3K2026-07-31 · Moran Timothy P. sold $198.0K2026-07-31 · Umberger Traci S sold $197.8K2026-07-31 · Ford Alfred J Jr sold $196.3K2026-08-03 · Umberger Traci S sold $181.1K2026-07-30 · Webster Brian Daniel sold $178.5K2026-05-15 · Webster Brian Daniel sold $167.4K2026-08-04 · Ford Alfred J Jr sold $151.1K2026-05-15 · Webster Brian Daniel sold $146.9K2026-09-08 · Hanley Conor sold $143.8K2026-07-30 · Ford Alfred J Jr sold $135.1K2026-07-30 · Umberger Traci S sold $133.9K2026-08-03 · Mahboob Vaseem sold $128.3K2026-10-21 · Umberger Traci S sold $101.0K2026-08-04 · Mahboob Vaseem sold $98.5K2026-09-08 · Ladone Mary Kay sold $98.5K2026-09-08 · Schwartz Jeffrey Lawrence sold $97.9K2026-09-30 · COHEN RAYMOND W sold $97.5K2026-09-21 · Kwo Elizabeth sold $97.3K2026-07-30 · Moran Timothy P. sold $93.8K2026-07-30 · Mahboob Vaseem sold $90.6K2026-08-04 · Umberger Traci S sold $86.1K2026-02-17 · Webster Brian Daniel sold $86.0K2026-08-04 · Mahboob Vaseem sold $74.1K2026-09-08 · Reilly Kevin C sold $73.7K2026-10-21 · Umberger Traci S filed to sell $2.7M2026-10-20 · Webster Brian Daniel filed to sell $443.4K2026-09-30 · COHEN RAYMOND W filed to sell $97.5K2026-09-21 · Kwo Elizabeth filed to sell $97.3K2026-09-08 · Hanley Conor filed to sell $143.8K2026-09-08 · Jeffrey Lawrence Schwartz filed to sell $97.9K2026-09-08 · Ladone Mary Kay filed to sell $98.5K2026-09-08 · Reilly Kevin C filed to sell $73.7K2026-08-17 · Webster Brian Daniel filed to sell $412.2K2026-08-07 · Mahboob Vaseem filed to sell $680.4K2026-08-04 · Ford Alfred J Jr filed to sell $151.1K2026-08-04 · Mahboob Vaseem filed to sell $172.6K2026-08-04 · Umberger Traci S filed to sell $86.1K2026-08-04 · Webster Brian Daniel filed to sell $1.3M2026-08-03 · Ford Alfred J Jr filed to sell $311.1K2026-08-03 · Webster Brian Daniel filed to sell $311.4K2026-08-03 · Moran Timothy P. filed to sell $56.6K2026-08-03 · Umberger Traci S filed to sell $181.1K2026-08-03 · Mahboob Vaseem filed to sell $128.3K2026-07-31 · Ford Alfred J Jr filed to sell $196.3K
Insider buyInsider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns KMTS: institutional holders (13F)

13F holdings, latest reported quarter
Bain Capital Investors LLC
25,172,338 sh
$640.4M
FMR LLC
5,523,647 sh
$140.5M
ANDERA PARTNERS
2,728,679 sh
$69.4M
Yu Fan
2,282,519 sh
$58.1M
BROWN ADVISORY INC
1,909,056 sh
$48.6M

Congress trades in KMTS

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

KMTS planned insider sales (Form 144)

Notice of intent to sell, filed before any sale
Umberger Traci S
Filed 2026-10-21
$2.7M
Webster Brian Daniel
Filed 2026-10-20
$443.4K
COHEN RAYMOND W
Filed 2026-09-30
$97.5K
Kwo Elizabeth
Filed 2026-09-21
$97.3K
Hanley Conor
Filed 2026-09-08
$143.8K

KMTS mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
Eventide Healthcare & Life Sciences Fund
$34.8M position · as of 2026-06-30
1.9%
Eventide Exponential Technologies Fund
$2.0M position · as of 2026-06-30
1.9%
RiverPark/Next Century Growth Fund
$79.8K position · as of 2026-06-30
0.7%
Global X HealthTech ETF
$132.1K position · as of 2026-05-31
0.5%
Dunham Small Cap Growth Fund
$378.5K position · as of 2026-07-31
0.5%
SmallCap Growth Fund I
$10.3M position · as of 2026-07-31
0.4%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $10.1M sold by insiders over 180 days, 72 funds added last quarter, $9.2M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
PENBLFSMTDSIBNWRBYISRGTXGDXCMEWTMDXOMIRMD

KMTS financials

Revenue growth
+59.0%
XBRL, annual
Net margin
-138.4%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$106.7M
four quarters, 2025-08-01 to 2026-07-31
Net margin, TTM
-140.4%
net income over revenue, 2025-08-01 to 2026-07-31
Free cash flow, TTM
-$122.8M
operating cash flow minus capex, 2025-08-01 to 2026-07-31
Debt to equity
0.33x
long-term debt only, 2026-07-31; equity 2026-07-31
Cash flow to debt
-1.21x
TTM operating cash flow over long-term debt only, 2026-07-31
Return on equity
-73.7%
TTM net income over average of 2025-07-31 and 2026-07-31
Return on assets
-48.8%
TTM net income over average of 2025-07-31 and 2026-07-31
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
Return on capital employed
-53.8%
operating income (EBIT proxy) over average of 2025-07-31 and 2026-07-31 minus current liabilities
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Enterprise value
$1.7B
market value at close 2026-10-23 on 2026-09-11 shares, plus long-term debt only, 2026-07-31, minus cash 2026-07-31
FCF yield
-7.2%
TTM free cash flow over market value at close 2026-10-23
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2026-042025-042024-04
Revenue$95.1M$59.8M$27.8M
Gross profit$48.9M$24.2M$362.0K
Operating income-$134.7M-$106.4M-$85.1M
Net income-$131.6M-$113.8M-$94.1M
EPS (diluted)-2.43-5.13-5.07
Operating cash flow-$81.7M-$77.6M-$72.2M
Cash$99.7M$237.6M$8.2M
Long-term debt$42.6M$41.1M$42.5M
SEC XBRL, fiscal years, as known on 2026-10-27

KMTS Stock Sonar score 6/7 axes

Find similar shapesCompare

KMTS ranks highest on growth (88th percentile) and risk and compliance (63rd), and lowest on insider conviction (8th), among Medical Devices peers.

ProfitHealthGrowthInsidersInstitutionsRisk
Profitability
31
Inputs
  • Return on equity-73.7% · 32 pct, sector of 183
  • Return on assets-48.8% · 31 pct, sector of 214
  • Return on invested capitalpre-tax loss, no effective tax rate to apply
  • Return on capital employed-53.8% · 30 pct, sector of 188
Financial health
38
Inputs
  • Debt to equity0.33x · 47 pct, sector of 159
  • Cash flow to debt-1.21x · 29 pct, sector of 150
Growth
88
Inputs
  • Revenue growth, YoY+59.0% · 88 pct, sector of 219
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
8
Inputs
  • Net Form 4 buying (codes P and S), 180d-$7.0M · 16 pct, sector of 140
  • Insider buyers, 180d0 · 0 pct, sector of 142
Institutional and government
55
Inputs
  • Funds adding, latest quarter72 · 55 pct, sector of 191
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
63
Inputs
  • Short interest, % of float+9.7% · 23 pct, sector of 240
  • Recalls per $1B revenue, 3y0.00 per $1B · 100 pct, sector of 116
  • EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
  • New text in Risk Factors, latest 10-K+7.8% · 66 pct, sector of 198
1 not measured: US patents
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

KMTS filings, in plain words

Are Kestra Medical Technologies insiders buying or selling KMTS?

In the 180 days to 2026-10-27, Kestra Medical Technologies insiders were net sellers, a net $10.1M across purchases and sales reported on Form 4, by 11 sellers.

Are there planned insider sales of KMTS?

Yes. 29 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $9.2M of stock; the latest, by Umberger Traci S, was filed 2026-10-21.

Read the full summary

In the 180 days to 2026-10-27, Kestra Medical Technologies insiders were net sellers of KMTS, a net $10.1M across purchases and sales reported on Form 4 by 11 sellers. 10% of the 41 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. Insiders filed 29 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $9.2M of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies